Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • U vs MRNA✓SelectedUSD · MRNAU vs MRNA performance historyLatest closeAs of-2.78%11/18
Stock and ETF performance explorer

U vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-28.4%
MRNA return
+188.2%
Excess return
-216.6%
Maximum drawdown
-93.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.8%-4.8%+2.1%-2.1%
7D-1.4%-20.9%+19.5%+1.7%
30D+20.7%-13.3%+33.9%+22.3%
3M+4.7%+212.6%-207.8%-23.7%
6M+82.7%+309.0%-226.4%+20.4%
YTD+10.8%+567.3%-556.5%-39.0%
1Y+32.3%+689.7%-657.4%-31.4%
3Y+67.7%+157.4%-89.8%+10.6%
5Y-75.7%-21.7%-53.9%-78.2%
All-28.4%+188.2%-216.6%-60.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling